| Literature DB >> 32321963 |
João Albuquerque1,2, Susana Casal1, Ricardo Nuno Mendes de Jorge Páscoa1, Ingrid Van Dorpe3, António José Mira Fonseca4, Ana Rita Jordão Cabrita5, Ana Rute Neves1,6, Salette Reis1.
Abstract
The amino acid requirements of high-production dairy cows represent a challenge to ensuring that their diet is supplied with available dietary resources, and thus supplementation with protected amino acids is necessary to increase their post-ruminal supply. Lysine is often the most limiting amino acid in corn-based diets. The present study proposes the use of lipid nanoparticles as novel rumen-bypass systems and assesses their capability to carry lysine. Solid lipid nanoparticles, nanostructured lipid carriers and multiple lipid nanoparticles were considered and their resistance in a rumen inoculum collected from fistulated cows was assessed. All nanoparticles presented diameters between 200-500 nm and surface charges lower than -30 mV. Lysine encapsulation was achieved in all nanoparticles, and its efficiency ranged from 40 to 90%. Solid lipid nanoparticles composed of arachidic or stearic acids and Tween 60 resisted ruminal digestion for up to 24 h. The nanoparticles were also proven to protect their lysine content from the ruminal microbiota. Based on our findings, the proposed nanoparticles represent promising candidates for rumen-bypass approaches and should be studied further to help improve the current technologies and overcome their limitations.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32321963 PMCID: PMC7176649 DOI: 10.1038/s41598-020-63793-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Mean diameter, PdI and zeta potential values for all tested NP, n = 3.
| NP formulation | Mean diameter (nm) | PdI | Zeta potential (mV) |
|---|---|---|---|
| SLN – Stearic acid * | 444 ± 11a | 0.25 ± 0.02a | −35 ± 2a |
| SLN – Stearic acid # | 265 ± 82b | 0.14 ± 0.02a | −31 ± 1a |
| SLN – Arachidic acid * | 385 ± 37a | 0.20 ± 0.02a | −37 ± 1a |
| SLN – Arachidic acid # | 131 ± 79b | 0.12 ± 0.03a | −34 ± 1a |
| SLN – Precirol ATO 5 * | 511 ± 50a | 0.25 ± 0.01a | −35 ± 2a |
| SLN – Compritol 888 ATO * | 556 ± 10a | 0.17 ± 0.01a | −36 ± 2a |
| NLC – Stearic acid * | 332 ± 40a | 0.17 ± 0.02a | −39 ± 1a |
| NLC – Arachidic acid * | 412 ± 25a | 0.22 ± 0.02a | −46 ± 4a |
| NLC – Precirol ATO 5 * | 270 ± 60b | 0.18 ± 0.01a | −39 ± 1a |
| NLC – Compritol 888 ATO * | 287 ± 45b | 0.19 ± 0.03a | −38 ± 1a |
| MLN – Stearic acid * | 216 ± 16b | 0.41 ± 0.01b | −60 ± 1b |
| MLN – Arachidic acid * | 208 ± 16b | 0.39 ± 0.01b | −59 ± 1b |
*Prepared with Tween 60 as the surfactant.
#Prepared with Tween 80 as the surfactant.
Values followed by different letters are statistically significantly different (p < 0.05).
Figure 1Diameter of SLN composed of stearic (A) and arachidic (B) acids with Tween 60 and zeta potential values for the same SLN (C and D, respectively) during the rumen stability assay. Results are shown for blanks and supernatants that contain bacteria (T0 and Tf) and deposits that contain NP (Ti, T0 and Tf), n = 6. *Statistically significant difference (p ≤ 0.05) from the blanks. #NP were statistically significantly different (p ≤ 0.05) from Ti NP.
Figure 2Diameters of SLN composed of arachidic acid (A) with Tween 80, NLC (B) and MLN (C) composed of arachidic acid measured during the rumen stability assay. Results are shown for blanks and supernatants that contain bacteria (T0 and Tf) and deposits that contain NP (Ti, T0 and Tf), n=6. *Statistically significantly different (p ≤ 0.05) from the blanks. #NP were statistically significantly different (p ≤ 0.05) from Ti NP.
Figure 3TEM photographs of both arachidic acid (A) and stearic acid (S) SLN with Tween 60. Ti – NP after synthesis, T0 – NP after contact with the rumen inoculum, Tf – NP after a 24 h incubation with the rumen inoculum, and SN - supernatant.
Lysine encapsulation efficiency (%Lys) for SLN, NLC and MLN composed of arachidic or stearic acid with Tween 60 as the surfactant, and the amount of Lys (mg) per gram of NP, n = 3.
| NP Formulations | %Lys | Lys mg/g of NP |
|---|---|---|
| SLN – Stearic acid | 39 ± 5a | 16 ± 2 |
| SLN – Arachidic acid | 38 ± 6a | 16 ± 3 |
| NLC – Stearic acid | 64 ± 3b | 27 ± 1 |
| NLC – Arachidic acid | 61 ± 5b | 25 ± 2 |
| MLN – Stearic acid | 82 ± 3c | 39 ± 1 |
| MLN – Arachidic acid | 92 ± 2c | 43 ± 1 |
Values followed by different letters are statistically significantly different (p < 0.05).
Figure 4PLS models obtained at T0 (0 h of incubation) for NP with Lys added after production (A) or encapsulated during production (C) and Tf (24 h of incubation) for NP with Lys added after production (B) and encapsulated during production (D). Values of R2CV and RMSECV are shown for each model.
Different combinations of solid lipids, liquid lipids and surfactants tested for NP production.
| Type of NP | Solid lipid | Liquid lipid | Surfactant |
|---|---|---|---|
| SLN | Stearic acid | ------------- | Tween 60 |
| SLN | Stearic acid | ------------- | Tween 80 |
| SLN | Stearic acid | ------------- | poly(vinyl alcohol) |
| SLN | Arachidic acid | ------------- | Tween 60 |
| SLN | Arachidic acid | ------------- | Tween 80 |
| SLN | Arachidic acid | ------------- | poly(vinyl alcohol) |
| SLN | Precirol ATO 5 | ------------- | Tween 60 |
| SLN | Compritol 888 ATO | ------------- | Tween 60 |
| NLC | Stearic acid | Miglyol 812 | Tween 60 |
| NLC | Arachidic acid | Miglyol 812 | Tween 60 |
| NLC | Precirol ATO 5 | Miglyol 812 | Tween 60 |
| NLC | Compritol 888 ATO | Miglyol 812 | Tween 60 |
| MLN | Stearic acid | Miglyol 812 | SPAN 80 + Tween 60 |
| MLN | Arachidic acid | Miglyol 812 | SPAN 80 + Tween 60 |
Precirol ATO 5 consists of esters of palmitic (C16) and stearic (C18) acids, and the diester fraction is predominant.
Compritol 888 ATO consists of mono-, di- and triesters of behenic acid (C22), and the diester fraction is predominant.